Summary Two cohorts of women born in 1914-18 and 1929-33 who participated in a cervical screening programme have been followed for over 40 years. Age-specific incidence rates of squamous carcinoma of the cervix by rank of smear and length of interval between smears are reported. The younger cohort, who had undergone more frequent screening, had lower rates of invasive disease. From these incidence rates, estimates of false-negative rates and regression rates for carcinoma in situ have been made. The false-negative rate was estimated to be about 15%. Regression seemed more frequent in younger than in older women. For the younger cohort it was estimated to be 72% and in the older 47%. Before the updating of the cohort data was attempted it was realised that, for many of the women, no post-1969 records would exist, since, before or soon after 1970, some of the women would have died from causes other than cervical cancer, some would have had a hysterectomy and some would have left the province. During the 1970s some culling of the files in the cytology laboratory took place. The files of women who had had nothing but negative smears, no histology and had not had a smear taken in the previous 7 years, or were known to be dead, were deleted. Interpolating from the data on annual terminations of surveillance, it would appear that the files of approximately 10% of the women were removed.
A cervical cytology screening programme was established in British Columbia in 1949. In the early 1970s, when approximately 85% of women aged 20 years and over in the province were enrolled in the programme (Boyes et al., 1981) , an investigation into the true incidence and prevalence of cancer of the cervix was carried out in two cohorts of women (Boyes et al., 1982) . Cohort I consisted of women born in the years 1914-18 and cohort II were those born in the years 1929-33. The two cohorts differed in age by 15 years and were chosen in order that the rates of various stages of the disease could be investigated over a wide age range.
This study, which involves an updating of the earlier one, reports age-specific incidence rates for carcinoma in situ or invasive cancer in the two cohorts over a period of more than 40 years, 1949-92. The age range covered is from 16 to 78 years. During the last few decades many reports have documented a decrease in invasive disease in the western world. It is not clear what proportion of this decrease is owing to the earlier detection and treatment of dysplasia and carcinoma in situ. Soon most women in North America and western europe will have regular cervical smears from their early adult life, it is so important to assess the effect of such screening on future incidence rates of invasive disease.
Subjects and methods
The two original cohorts comprised women who, before 1970, had had at least one smear, had undergone at least one gynaecological surgical procedure generating a pathology report, or had died of cervical cancer. In total, 119 153 women were included: 52 452 of whom were in cohort I and 66 701 in cohort II. In its cytology laboratory the British Columbia Cancer Agency maintains records of all cytology smears and gynaecological histology records for all women screened or treated in the province. In the early 1970s the handwritten records for the two cohorts were taken from the cytology laboratory, edited and recorded on magnetic tape. Each smear or pathology report formed one record on the tape and each record contained identifying information about the women concerned. The identifying information consisted of the following: last name, first eight characters of first name, middle initial, birth month, birth year, first four characters of husband's first name. The smear report information that was recorded was the class of the smear (I-V) as read by the technician and the unique identifying number for that smear. For those women who later developed an abnormality, a reviewed class of the smear was also given. It was used as the basis of the analyses in the former paper but in this paper only the class as initially read by the technician has been used. The pathology report contained the type of tumour cells (squamous, adeno or mixed), the stage of the disease and the treatment.
Before the updating of the cohort data was attempted it was realised that, for many of the women, no post-1969 records would exist, since, before or soon after 1970, some of the women would have died from causes other than cervical cancer, some would have had a hysterectomy and some would have left the province. During the 1970s some culling of the files in the cytology laboratory took place. The files of women who had had nothing but negative smears, no histology and had not had a smear taken in the previous 7 years, or were known to be dead, were deleted. Interpolating from the data on annual terminations of surveillance, it would appear that the files of approximately 10% of the women were removed.
Before proceeding with the update an attempt was made to estimate from the smear and pathology records of the original cohorts that were on magnetic tape the number of women who had a very low probability of being linked. They fell into two groups. The first group were women without histology records and only a single smear which was taken before 1967. The authors considered that women below age 55 with a gap without a smear in the years 1967-70 (when many families returned to the eastern provinces) and with only a single smear preceding, was a strong indication of a transient resident. The second group were those who, before 1970, had had a hysterectomy for reasons other than cervical cancer or its precursive abnormalities, or who had died of cervical cancer. In cohort I, 12 923 women fell into these two groups, and in cohort II 14 537. These women, however, were included in all matching attempts since it was easier to leave their records in the files and because there was a slight probability that a linkage might be made. 
Results
The women in the younger cohort had an average of 9.78 smears with a mean interval of 20.87 months between the smears, whereas the women in the older cohort averaged only 8.02 smears with a mean interval of 22.59 months.
Before the following analyses were carried out, smear records that appeared to have been taken for diagnostic purposes not screening purposes, were eliminated. Any cluster of two or more smears in which consecutive smears were less than 6 months apart was amalgamated into a single smear, which was then assigned the highest class observed in the cluster and the date of the first smear in the cluster.
The rates of disease that are presented pertain to squamous cell or mixed cell carcinoma of the cervix. Table Ia and b except that the denominators of the rates are the number of smear intervals of the specified length and smear rank, not the number of person -years at risk. In the case of the hypothetical 45-year-old woman her denominator contributions would be two counts of 1 in the 45 -49 age grouping, the first to the 12 -23 month interval and smear rank of 2, and the second to the 36-47 month interval and smear rank of 3. As for Table Ia and b, the age groups have been amalgamated.
In both tables, and in both cohorts, the risk of carcinoma in situ or invasive cancer decreases with the rank of the smear. A similar decrease in invasive cancer with the rank of the smear has been documented elsewhere by Clarke and 
Discussion
In Tables Ia and b and Ila and b the decrease in incidence with increasing smear rank is probably the result of three factors. The first and most obvious one is that at least for cohort II, the disease rates decrease with age and that age and rank are inevitably correlated. Consequently, even within a given age group, there will be some residual effect of the decrease with age. The other factor is that of selection. Fidler et al. (1968) showed that women who are at a low risk of disease tend to be conscientious about having regular smears. This is supported by examining the risk associated with smear rank before and after 1970 (partitioned data not presented). Before 1970, when new women were continuously entering the cohorts, there is a marked association between smear rank and risk of disease; after 1970, when no new women were entering, this association is much less evident. Artifactual selection, in that women who developed an abnormality were no longer considered to be at risk, was also operating. The increased risk across Table IIa and b is undoubtedly due to the longer intervals between smears providing women with a greater opportunity for developing the disease. The fact that the incidence rates are not lowest in the shortest interval, 0-11 months, suggests that the smear immediately preceding the one in the 0-11 month interval may have been a false negative. Fitting a regression line to the rates for the six intervals longer than 11 months and extrapolating it to the 0-11 month interval will give an 'expected' value for the incidence rate for that interval. The difference between the expected incidence rate and the observed rate should be the rate of disease which can be attributed to false negatives. To obtain the most accurate estimate it was necessary to use only the data pertaining to smears of rank 2 since those smears were the only ones where there was 100% certainty that the previous smear was a class 1. Another complication was that the incidence rates in the longer intervals could have been reduced by regression and, as a consequence, the slopes of the fitted lines would have been diminished. Using tables Tables Ia and b and Ila and b show opposite trends in risk across the smear intervals. The decreasing incidence across the screening intervals in Table Ia and b is probably a reflection of regression. In the shorter screening intervals, the rate of detection of transient lesions should be higher because there are more screenings per person-year and, hence, more opportunity to detect an abnormal state. Ignoring the rate in the 0 -11 month interval on the grounds that it may be contaminated by previous false negatives, and testing the decrease across the remaining intervals, shows a significant (P = 0.003, P = 0.007) linear association in both cohorts between the rate of carcinoma in situ or invasive cancer and the length of the screening interval. Applying the same analyses to the incidence of clinical cancer demonstrates that there is no significant decrease in the rates across the screening intervals (P=0.781, P=0.599), reflecting the fact that invasive cancer does not regress.
A crude estimate of the proportion of carcinoma in situ that does not regress can be obtained by dividing the overall incidence rate (person -years) for the longest interval (120+months) by the overall incidence rate for the shortest interval (0-11 months). As we have just demonstrated, however, the magnitude of the latter rate is inflated by false negatives from the previous smear and, therefore, it is probably wiser to use the rate for the second shortest interval and assume that the resulting ratio may be an overestimate. The complement of this proportion may then be an underestimate of the proportion of carcinoma in situ that does regress. For cohort I this estimate is 1-(0.33/ 0.62) =0.47, and for cohort II it is 1-(0.27/0.96)= 0.72. These figures are higher than those derived by different methods in the original paper by Boyes et al. (1982) , but that is to be expected as a longer time span is covered. The figures are lower than those derived from Swedish data (88%) by Gustafsson and Adami (1989) (Figures 2 and 4 ). The ratios of the incidence of clinically invasive disease in the two cohorts as shown in Table IV 
